Tonghua sells Indian Iressa 18877777336 purchasing gefitinib

The Indian version of Iressa has the same efficacy as the British version of Iressa Shukang Pharmaceutical Company} Mr. Huang

Let’s discuss the Indian version of Iressa and the British version of Iressa from the perspective of pharmacology and pharmaceutical technology. Today we although There are no clinical trials comparing these two drugs, but it is certain that in clinical practice, the ingredients and efficacy of the two are exactly the same.

First of all, because the ingredients of the British and Indian versions of Iressa are the same, pharmacologically speaking, if they are resistant, they will become resistant together, and taking them in turns will not reduce the resistance. The official launch of Iressa in India is due to the use of different production processes.

Secondly, it is whether the effective content of the drug is stable. Because the dilution of the drug is carried out in batches multiple times, the process is very simple, and there should be no problem for a large factory like the Indian version of Iressa. (Pharmaceutical Group is the second largest group in India, and according to its own company, it is the strongest in the world.) Moreover, India itself is a country with a very developed generic drug industry. As soon as expensive drugs produced by Western countries are put on the market, under the protection of its own patent laws, India can imitate the same drugs, and the relative price will be several times lower. This has greatly benefited hundreds of millions of Indian people who are also in developing countries.

Thirdly, it is the control of excipients, temperature, time, pH, bioavailability, etc. during the production process. For drugs that are greatly affected by the above factors, such as certain vitamins, etc., the efficacy will be affected. Certain impact. However, from the packaging of Iressa and its taking method, it can be dissolved in boiling water before taking, indicating that Iressa is a relatively stable pharmaceutical preparation with stable bioavailability. For large manufacturers, the control of the production process will not be too difficult. So don't worry too much.

Therefore, the quality of medicines produced in India is very reliable. If you buy Iressa directly from formal channels in India, the possibility of counterfeit medicine is very low. Because the cost of APIs is quite low, there is no need for local pharmaceutical companies to fake them.

The company has a strict quality monitoring system to supervise the quality of its medicines. Each batch of medicines will be randomly inspected in accordance with regulations and must be qualified before leaving the factory.

Pharmaceuticals and pharmaceuticals are two pillar industries in India. The company is a large group pharmaceutical company. However, they often face intellectual property disputes and are frequently brought to court by pharmaceutical companies in the United Kingdom and the United States. Last year, Tarceva was forced to suspend production. Fortunately, Tarceva has resumed production recently. Regardless of whether Tarceva is discontinued or resumed, Gleevec and Iressa will not be affected, because they submitted their application to the Indian government. The manufacturing license report predates the implementation of world patent laws in India.

Why can't China produce low-priced Iressa?

Many patients don't understand this, because Iressa in the UK is expensive and only a small number of families can afford it. It has long been responsible for the monthly drug cost of RMB 10,000, and even if Chinese pharmaceutical companies have the technology to synthesize gefitinib, they cannot obtain the production license approval of the national drug brand issued by the State Food and Drug Administration. The main reason is the issue of international intellectual property protection laws. Of course, there are also African countries with backward economies and a high incidence of AIDS, and imported drugs in developed countries are expensive, so national demonstrations often take place to protect domestic companies that produce domestically produced anti-cancer drugs or import high-quality and low-priced anti-cancer drugs from India.